Pular para o conteúdo principal
Ranking Invest

SMTI - Sanara MedTech Inc.

Segmento: HealthcareSanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako's Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Análise Ranking Invest

Valuation estimado
-$ 55.24 Mi
Valor de Mercado
$ 320.94 Mi
Desconto (AV)-681.0%
IVR
-0.17A companhia vale -0,17 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.19O valuation alternativo equivale a -19% do valor de mercado da companhia.
MLL
-0.19O lucro líquido dos controladores em 16 trimestres equivale a -19% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 7.95 Mi

Dívida Líquida

$ 31.06 Mi

L4T

-$ 32.01 Mi

MM4T

-30.32%

Indicadores Básicos

ROE

-402.58%

Índices de Previsibilidade

Receita Líquida

B0.04

Lucro

D0.71

Margem

D1.00

Índices de Tendência

Receita Líquida

A11.58

Lucro

B4.93

Margem

B5.95

Índices de Endividamento

DIV/PAT

3.91

DIV/L4T

-0.97

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.